← brief for 2026-10-24 · Slowing decline

Liver fibrosis risk, missed follow-up, and inequitable specialist referral in the All of Us Research Program: a retrospective cohort study

Key takeaways

Who did this work

Sellers K (City University of New York Graduate School of Public Health & Health Policy (CUNY SPH), New York, NY, USA) · White T (City University of New York Graduate School of Public Health & Health Policy (CUNY SPH), New York, NY, USA) · Manolas M (Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, New York, NY, USA) · Hagström H (Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden) · Brennan P (School of Medicine, University of Dundee, Dundee, Scotland, United Kingdom) · Diaz L (Department of Gastroenterology, Pontificia Universidad Católica de Chile, Santiago, Chile) · Bansal M (Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA) · Danpanichkul P (Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA) · Zhang X (Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA) · Lazarus J (City University of New York Graduate School of Public Health & Health Policy (CUNY SPH), New York, NY, USA)

Source

Article · Europe PMC, CKD · 2026-10-19
https://europepmc.org/article/PMC/PMC13691157